Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in adults. This approach not only attacks tumor cells directly but also reprograms the tumor's microenvironment, enabling immune cells to fight the cancer rather than protect it.
